Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy

Reirradiation with SBRT is feasible although increased risk of toxicity was reported in centrally located tumours. Further research is warranted for more accurate selection of patients suitable for reirradiation with SBRT.